Search the Newsreel

How (HASI) Movements Inform Risk Allocation Models

This article analyzes Hannon Armstrong Sustainable Infrastructure Capital Inc. (NASDAQ: HASI) using AI models, indicating strong sentiment across all horizons and an exceptional 25.3:1 risk-reward setup. It outlines specific institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with entry, target, and stop-loss …

Consensus Cloud Solutions (CCSI) CTO Sullivan sells 5,400 shares at ~$37.70

Consensus Cloud Solutions, Inc. (CCSI) Chief Technology Officer Jeffrey Alan Sullivan sold 5,400 shares of common stock on August 12, 2026, at a weighted average price of approximately $37.70 per share. This transaction, which was an open-market or private sale, leaves Sullivan with a …

Kura Sushi USA (KRUS) investor Divisadero Street exits with 0% reported stake

Divisadero Street Capital Management, LP and its related entities have filed an amended Schedule 13G/A, indicating they no longer beneficially own any Class A Common Stock in Kura Sushi USA, Inc. The filing reports a 0% stake and 0 shares beneficially owned for all …

Versus Systems Inc. Q2 2026: Revenue $1.49M, EPS $0.1— 10-Q Summary

Versus Systems Inc. reported its Q2 2026 financial results, with revenue of $1.49 million and diluted earnings per share of $0.1. The company experienced a decline in revenue and a modest slip in earnings compared to the previous year. While related-party revenue decreased, third-party …

Versus Systems (NASDAQ: VS) secures $1.7M from ASPIS but flags going concern risk

Versus Systems (NASDAQ: VS) reported Q2 2026 revenues of $1.49 million, largely from a related-party license with ASPIS, and secured $1.7 million from ASPIS through a common stock sale. Despite this funding boosting stockholders' equity and helping regain Nasdaq compliance, management flagged substantial doubt …

Versus Systems Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary

Sensus Healthcare, Inc. (SRTS) reported a significant decline in its Q2 2026 financial results, with revenue falling to $2.29M and diluted EPS at $(0.53). This downturn was primarily attributed to fewer system sales, a shift towards Fair Deal Agreements and rental arrangements impacting revenue …

Hood River Capital (KRUS) reports 0% ownership of Kura Sushi USA common stock

Hood River Capital Management LLC has filed an amended Schedule 13G, reporting that it no longer holds any shares of Kura Sushi USA Inc. common stock, bringing its ownership down to 0%. The firm also indicates that it has no voting or dispositive power …

Universus Photo Imagings Share Price Target 2027 to 2030: Analyst

Prosus-aandeel test steun op €35,75: Technische vooruitzichten

Acusensus (ASX:ACE) Surges as Road Safety Technology Captures Strong Demand

Sensus outlines shift to $250,000 average selling price as it targets a stronger second half

Earnings Call Insights: Sensus Healthcare (SRTS) Q2 2026 MANAGEMENT VIEW * "During the quarter, we secured equipment orders that we expected to be recognized in Q2. Third-party financing approval was not completed before June 30... which prevented us from recognizing 19 units and related …

Sensus Healthcare Q2 Adjusted Ebitda USD -3.0

This article reports that Sensus Healthcare's Q2 Adjusted EBITDA was USD -3.0. The content provided is extremely minimal, offering only this single financial data point.

Tarsus Pharmaceuticals (TARS) Stock Looks Reasonable On Sales While Earnings Stay Weak

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Tarsus Pharmaceuticals stock has delivered a very large 3 year return, yet the broader valuation checks still suggest it trades on the cheap …

Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69%

Sensus Healthcare reported a significant decline in Q2 2026 revenue, falling 69% year-over-year to $2.3 million, missing analyst estimates. The company's net loss widened to $8.7 million, or $0.53 per share, primarily due to lower unit sales and delayed revenue recognition, along with a …

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS

Sensus Healthcare (NASDAQ:SRTS) announced its quarterly earnings, reporting a significant miss on both EPS and revenue expectations. The company posted a loss of $0.53 per share against an anticipated loss of $0.12, and revenue of $2.29 million, well below the $4.60 million estimate. Despite …

Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours

Sensus Healthcare reported a significant drop in Q2 revenue to $2.3 million from $7.3 million year-over-year, primarily due to delayed third-party financing for eight equipment units. The company expects to recognize this delayed revenue in Q3, leading to anticipated stronger second-half results. Sensus is …

Sensus Healthcare Inc (SRTS) Faces Challenges in Q2 Earnings: Re

CMS Proposes 26% Increase in Sensus Hospital Delivery Code

Sensus Healthcare (SRTS) announced its Q2 2026 financial results, reporting a decrease in revenue to $2.3 million due to delayed financing approvals for eight units, which will now be recognized in Q3. Despite the revenue dip, the company noted strong commercial execution and a …

Silver Pegasus Acquisition Corp. 6M 2026: Net income $976280 EPS $0.06— 10-Q Summary

Silver Pegasus (SPEG) earns $976K on Trust interest but faces 2027 deadline

Silver Pegasus Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Tarsus (TARS) Q2 2026 Earnings Call Transcript

Janus Henderson Group Ltd. (TARS) discloses 6.5% beneficial stake in Tarsus

Janus Henderson Group Ltd. has disclosed a 6.5% beneficial ownership stake in Tarsus Pharmaceuticals, Inc., totaling 2,808,796 shares of common stock. This ownership is held through its affiliated asset managers via Managed Portfolios, where they exercise investment and voting discretion. The filing indicates shared …

Kura Sushi USA (KRUS): Stephens group discloses 1.10M-share, 9.9% ownership stake

Stephens Inc. and affiliated entities have filed an Amendment No. 8, disclosing a beneficial ownership stake of 1,102,847 shares, representing 9.9% of Kura Sushi USA, Inc.'s Class A common stock as of June 30, 2026. The filing indicates shared voting and dispositive power over …

Kura Sushi USA, Inc. (NASDAQ:KRUS) Receives Consensus Recommendation of "Hold" from Analysts

Universus Photo Imagings reports consolidated net profit of Rs 45.33 crore in the June 2026 quarter

Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $100

Mizuho Securities analyst Graig Suvannavejh has reiterated a Buy rating for Tarsus Pharmaceuticals (TARS.US), maintaining a target price of $100. According to TipRanks data, Suvannavejh has a 52.0% success rate and a 24.3% average return over the past year. The information is provided for …

Consensus Cloud Solutions (CCSI) investor plans 5,400-share NASDAQ sale under Rule 144

Jeffrey Sullivan, a shareholder of Consensus Cloud Solutions (CCSI), plans to sell 5,400 shares of common stock on NASDAQ under Rule 144, valued at $203,583.78. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also details Sullivan's …

HA Sustainable Infrastructure Capital (HASI) Is Up 5.6% After Raising 2028 EPS Outlook And Dividend

Universus Photo Imagings Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating

Oppenheimer has increased its price target for Tarsus Pharmaceuticals (TARS) to $100 from $97, while maintaining an "Outperform" rating on the stock. This adjustment comes amidst recent company activities including an acquisition agreement with Alkeus Pharmaceuticals and Q2 2026 earnings results. Mizuho also recently …

Silver Pegasus Acquisition Corp (SPEG) Earnings Forecast: Future EPS & Revenue Growth Estimates